510(k) Report

510(k) · Cleared

Cleared

Elecsys FT4 Assay

K961489510(k) TraditionalCleared Jun 11, 199654-day reviewClass II21 CFR 862.1695

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boehringer Mannheim Corp. · CEC Radioimmunoassay, Free Thyroxine

Cleared on Jun 11, 1996 as substantially equivalent to K900883 (Boehringer Mannheim Corp., 1990) after a 54-day review. Its family tree reaches back 1 generation to 1990. 5 later devices descend from it.

Decided
Jun 11, 1996
Review
54 days
Class
Class II
Product code
CEC
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K900883 (1990). 5 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared2015: 1 descendant cleared2014: 1 descendant cleared2018: 1 descendant cleared2023: 1 descendant clearedK900883 · Enzymun Test (R) FT4 (Free Thyroxine) · Boehringer Mannheim Corp. · 19901990200020102020
Descendants, by generation 1 generation forward: 3 descendants2 generations forward: 2 descendants K900883 · Enzymun Test (R) FT4 (Free Thyroxine) · Boehringer Mannheim Corp. · 19900
  1. Root · 1 generation backK900883 Enzymun Test (R) FT4 (Free Thyroxine)Boehringer Mannheim Corp. · 1990
  2. This deviceK961489 Elecsys FT4 AssayBoehringer Mannheim Corp. · 1996
  3. Descendant · cites it directly · 2 of its ownK131244 Elecsys FT4 II Assay, Elecsys FT4 II CalsetRoche Diagnostics · 2014
  4. Descendant · 2 generations on · 0 of its ownK220456 Elecsys FT4 IVRoche Diagnostics · 2023
  5. Descendant · 2 generations on · 0 of its ownK181233 Elecsys FT4 IIIRoche Diagnostics · 2018
  6. Descendant · cites it directly · 0 of its ownK132058 Vidas FT4Biomerieux S.A. · 2015
  7. Descendant · cites it directly · 0 of its ownK121951 Liaison FT4 Liaison Control Thyroid 1 Liaison Control Thyroid 2…DiaSorin, Inc. · 2013

Most influential descendants

Showing 5 of 5 · See all
  • K131244Elecsys FT4 II Assay, Elecsys FT4 II CalsetRoche Diagnostics · 2014 · cites it directly2descendants
  • K220456Elecsys FT4 IVRoche Diagnostics · 2023 · 2 generations on0descendants
  • K181233Elecsys FT4 IIIRoche Diagnostics · 2018 · 2 generations on0descendants
  • K132058Vidas FT4Biomerieux S.A. · 2015 · cites it directly0descendants
  • K121951Liaison FT4 Liaison Control Thyroid 1 Liaison Control Thyroid 2 Liaison Control Thyroid 3DiaSorin, Inc. · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K900883Enzymun Test (R) FT4 (Free Thyroxine)Boehringer Mannheim Corp.1990—
0 (this device)K961489Elecsys FT4 AssayBoehringer Mannheim Corp.1996—
+1K131244Elecsys FT4 II Assay, Elecsys FT4 II CalsetRoche Diagnostics2014—
+2K220456Elecsys FT4 IVRoche Diagnostics2023—
+2K181233Elecsys FT4 IIIRoche Diagnostics2018—
+1K132058Vidas FT4Biomerieux S.A.2015—
+1K121951Liaison FT4 Liaison Control Thyroid 1 Liaison Control Thyroid 2 Liaison…DiaSorin, Inc.2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
201410
201510
201810
202310
FIG. 1 — Lineage of K961489, 1990–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CEC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CEC device

  1. #1 K240273 Access Free T4score 7.0 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K900883Enzymun Test (R) FT4 (Free Thyroxine)
Summary page 1
…e assay for the determination of free thyroxine (FT4). Classification name: Radioimmunoassay, Free Thyroxine We claim substantial equivalence to the Enzymun-Test® FT4 (K900883) The Elecsys® test principle is based on competition principle. Total duration of assay: 18 minutes (37° C). *Ist incubation (9…
Boehringer Mannheim Corp.1990—

What descends from it? (5)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K131244Elecsys FT4 II Assay, Elecsys FT4 II CalsetRoche Diagnostics20142
K132058Vidas FT4Biomerieux S.A.20150
K121951Liaison FT4 Liaison Control Thyroid 1 Liaison Control Thyroid 2 Liaison Control Thyroid 3DiaSorin, Inc.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K131244 (Roche Diagnostics, 2014) has gone furthest, with 2 descendants of its own.

How does its category compare?

All CEC devices

CEC Radioimmunoassay, Free Thyroxine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CEC

1in 2024

2007: 12008: 22009: 12012: 12013: 22014: 32015: 12016: 12017: 12018: 22023: 12024: 1
2007high 3 (2014) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CEC

238in 2014

2014: 238 days median
2007high 238 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CEC

1in 2018

2010: 32013: 12018: 1
2007high 3 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CEC

213in 2025

2009: 22010: 72011: 152012: 62013: 62014: 402015: 1662016: 1482017: 1962018: 1992019: 1672020: 1062021: 962022: 812023: 992024: 2762025: 213
2007high 276 (2024) · low 0 (2007)2025

MAUDE reports naming product code CEC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
20091—02
20100—37
20110—015
20121—06
20132—16
20143238040
20151—0166
20161—0148
20171—0196
20182—1199
20190—0167
20200—0106
20210—096
20220—081
20231—099
20241—0276
20250—0213
20260—0—

What is it indicated for?

Immunoassay for the in vitro quantitative determination of free thyroxine in human serum and plasma.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K961489: Elecsys FT4 Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K961489

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026